FotiosKoumpourasMD

Rheumatology • New Haven, CT

Director Yale Lupus Program

Join to view full profile

Dr. Koumpouras is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Koumpouras' full profile

Already have an account?

Office
300 Cedar Street
TAC 525
New Haven, CT 06520
Phone+1 203-680-7050

Education & Training

Yale-New Haven Medical CenterFellowship, Rheumatology, 2004 - 2007
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2000 - 2003
St. George's University School of MedicineClass of 2000

Certifications & Licensure

CT State Medical License 2004 - 2025
PA State Medical License 2007 - 2024
NY State Medical License 2003 - 2009
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Fellow (FACR) American College of Rheumatology

Clinical Trials

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus Start of enrollment: 2016 Feb 16
Completed
Phase 2
JBT-101 in Systemic Lupus Erythematosus (SLE) Start of enrollment: 2017 Dec 21
Completed
Phase 2
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE Start of enrollment: 2017 Sep 12
Completed
Phase 4
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE Start of enrollment: 2021 Jan 20
Recruiting
Early Phase 1
Roles: Contact, Principal Investigator
Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) Start of enrollment: 2023 Dec 19
Recruiting
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

62 citations
Randomized, Double‐Blind, Placebo‐Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus
Cynthia Aranow, Diane L. Kamen, Maria Dall'Era, Elena Massarotti, Meggan Mackay
Arthritis & Rheumatology. 2015-07-01
28 citations
High-throughput identification of autoantibodies that target the human exoproteome.
Eric Y Wang, Yile Dai, Connor E Rosen, Monica M Schmitt, Mei X Dong
Cell Reports Methods. 2022-02-28
5 citations
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, P...
Joan T Merrill, Joel Guthridge, Miles Smith, Joshua June, Fotios Koumpouras
Arthritis & Rheumatology. 2023-12-01

Journal Articles

Chimeric antigen receptors: “CARs” in the fast lane for rheumatology
Nathan Johnson and Fotios Koumpouras, Current Opinion in Rheumatology, 5/2024

Press Mentions

'The future is bright.' Yale doctor helps to advance the fight against lupusMarch 7th, 2024
New Cell Therapy Program to Offer Hope for Patients with Severe LupusJune 14th, 2023
Two for OneJune 17th, 2024
Join now to see all

Professional Memberships

American College of Rheumatology - ACR
Fellow